ENALAPRILAT - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for enalaprilat and what is the scope of freedom to operate?

Enalaprilat is the generic ingredient in two branded drugs marketed by Chartwell Injectable, Dr Reddys, Hikma Farmaceutica, Hospira, and Biovail Labs Intl, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for enalaprilat. Three suppliers are listed for this compound.

Sponsor	Phase
University of Maryland, Baltimore	Phase 4
University of Guadalajara	Phase 2
Ethicare GmbH	Phase 2/Phase 3

Sponsor

Phase

University of Maryland, Baltimore

Phase 4

University of Guadalajara

Phase 2

Ethicare GmbH

Phase 2/Phase 3

US Patents and Regulatory Information for ENALAPRILAT

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Dr Reddys	ENALAPRILAT	enalaprilat	INJECTABLE;INJECTION	075578-001	Aug 22, 2000	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Hospira	ENALAPRILAT	enalaprilat	INJECTABLE;INJECTION	075571-001	Aug 22, 2000		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Biovail Labs Intl	VASOTEC	enalaprilat	INJECTABLE;INJECTION	019309-001	Feb 9, 1988		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Hikma Farmaceutica	ENALAPRILAT	enalaprilat	INJECTABLE;INJECTION	078687-001	Dec 23, 2008	AP	RX	No	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Biovail Labs Intl	VASOTEC	enalaprilat	INJECTABLE;INJECTION	019309-001	Feb 9, 1988	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Applicant

Tradename

Generic Name

Dosage

NDA

Approval Date

Patent No.

Patent Expiration

INJECTABLE;INJECTION

Feb 9, 1988

⤷ Sign Up

>Applicant

>Tradename

>Generic Name

>Dosage

>NDA

>Approval Date

>Patent No.

>Patent Expiration

Subscribe to access the full database, or Sign Up

US Patents:	0
Tradenames:	2
Applicants:	5
NDAs:	7
Drug Master File Entries:	8
Finished Product Suppliers / Packagers:	3
Raw Ingredient (Bulk) Api Vendors:	73
Clinical Trials:	11
Patent Applications:	5,046
What excipients (inactive ingredients) are in ENALAPRILAT?	ENALAPRILAT excipients list
DailyMed Link:	ENALAPRILAT at DailyMed

Drug Class	Angiotensin Converting Enzyme Inhibitor
Mechanism of Action	Angiotensin-converting Enzyme Inhibitors
Physiological Effect	Decreased Blood Pressure

ENALAPRILAT - Generic Drug Details

What are the generic sources for enalaprilat and what is the scope of freedom to operate?

Summary for ENALAPRILAT

Recent Clinical Trials for ENALAPRILAT

Pharmacology for ENALAPRILAT

Medical Subject Heading (MeSH) Categories for ENALAPRILAT

US Patents and Regulatory Information for ENALAPRILAT

Expired US Patents for ENALAPRILAT

Make Better Decisions: Try a trial or see plans & pricing